Latest news

Thumbnail image for Survey reveals low awareness of kidney cancer

Survey reveals low awareness of kidney cancer

A charity survey has highlighted an “urgent need” for earlier diagnosis of kidney cancer, revealing that, in 51 percent of cases, the disease is detected from scans relating to other health conditions.

30th January 2018

Thumbnail image for Sanofi snaps up Ablynx for 3.9bn euros

Sanofi snaps up Ablynx for 3.9bn euros

Sanofi has announced its intention to buy Belgian drugmaker Ablynx via a deal valued at around 3.9 billion Euros, beating Novo Nordisk to the finish line.

29th January 2018

Thumbnail image for Seven medicines leap closer to EU approval

Seven medicines leap closer to EU approval

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has put forward seven new medicines for approval in the region, including new treatment options for haemophilia A, diabetes, and a very rare genetic disorder.

29th January 2018

Thumbnail image for Takeda/Zinfadel terminate late-stage Alzheimer’s study

Takeda/Zinfadel terminate late-stage Alzheimer’s study

Alzheimer’s disease research has taken another hit with the termination of a Phase III study assessing the effect of diabetes drug pioglitazone on mild cognitive impairment (MCI) in patients with the condition.

26th January 2018

Thumbnail image for First-line use of lung cancer drug Zykadia gets NHS nod

First-line use of lung cancer drug Zykadia gets NHS nod

Final guidelines have now been published endorsing NHS use of Novartis’ Zykadia as a first line of attack for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), offering patients a new treatment option.

25th January 2018

Previous  --   15 16 17 18 19 20 21 22 23 24   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download